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Stigmasterol - a plant sterol with several pharmacological activities - is susceptible to oxidation when 
exposed to air, a process enhanced by heat and humidity. In this context, microencapsulation is a way 
of preventing oxidation, allowing stigmasterol to be incorporated into various pharmaceutical forms 
while increasing its absorption. Microparticles were obtained using a blend of polymers of sodium 
alginate, starch and chitosan as the coating material through a one-stage process using the external 
gelation technique. Resultant microparticles were spherical, averaging 1.4 mm in size. Encapsulation 
efficiency was 90.42% and method yield 94.87%. The amount of stigmasterol in the oil recovered from 
microparticles was 9.97 mg/g. This technique proved feasible for the microencapsulation of stigmasterol.
Uniterms: Stigmasterol/ microencapsulation. Microencapsulation. Sodium alginate/drugs coating. 
Chitosan/drugs coating. Starch/drugs coating. Natural polymers/drugs coating.
O estigmasterol, um fitoesterol com diversas atividades farmacológicas, é suscetível à oxidação quando 
exposto ao ar, calor e umidade. Neste contexto, a microencapsulação é uma forma de proteção contra 
oxidação, permitindo a incorporação do estigmasterol em diversas formas farmacêuticas e aumentar sua 
absorção. As micropartículas foram obtidas por gelificação iônica externa, em uma etapa, utilizando como 
revestimento polímeros naturais de alginato de sódio, amido de milho e quitosana. As micropartículas 
apresentaram formato esférico com tamanho aproximado de 1,4 mm. O rendimento foi de 94,87% e 
a eficiência média de encapsulação de 90,42%. A quantidade de estigmasterol no óleo recuperado das 
micropartículas foi de 9,97 mg/g. O método mostrou-se viável para a microencapsulação do estigmasterol.
Unitermos: Estigmasterol/microencapsulação. Microencapsulamento. Alginato de sódio/revestimento 
de fámacos. Quitosana/revestimento de fámacos. Amido/revestimento de fámacos. Polímeros naturais/
revestimento de fámacos.
INTRODUCTION
Phytosterols are triterpenes closely resembling 
cholesterol in both structure and function (Fernandes, 
Cabral, 2007; Marangoni, Poli, 2010). Many studies have 
demonstrated their ability to reduce serum cholesterol 
levels. Moreover, phytosterols present anti-inflammatory 
(Gomez et al., 1999; Moghadasian, 2000; Gabay et 
al., 2010), antinociceptive (Santos et al., 1995), anti-
atherogenic (Marangoni, Poli, 2010) and anti-diabetic 
activities (Panda et al., 2009). Epidemiologic and 
experimental studies also suggest that phytosterols may 
offer protection from some types of cancers, such as colon, 
breast and prostate cancer (Nórmen et al., 2001; Ifere et 
al., 2009).
Due to their chemical structure, phytosterols are 
poorly absorbed by the human body, and are subject to 
oxidation when exposed to air. This oxidation process is 
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enhanced by heating, exposure to light and by chemicals 
and enzymes, and can occur during cooking, food or 
medicine production or upon long-term storage (Lampi 
et al., 2002; Säynäjoki et al., 2003; Foley et al., 2010). 
The most common oxidation mechanism for sterols is 
autoxidation by triplet oxygen (3O2), a free radical reaction 
that starts with the abstraction of reactive allylic hydrogen 
at C7 (García-Lattas, Rodríguez-Estrada, 2011). The main 
oxidation products are hydroxyl, keto, epoxy and triol 
derivatives, all of which are polar products (Lampi et al., 
2002; García-Lattas, Rodríguez-Estrada, 2011).
Many natural sterols are unsaturated (mostly Δ5) and 
are conveniently designed as stenols while their saturated 
analogues are called stanols (Brooks, 1970; Brufau, 
Canela, Rafecas, 2008). Sterols can be quantified by the 
colorimetric Liebermann-Burchard reaction (Wall, Kelley, 
1947; Sabir et al., 2005), which is positive with stenols 
and negative with stanols (Brooks, 1970).
The medium in which phytosterol is dissolved has 
been shown to play an important role in the speed and 
mechanism of the formation of its oxidation products 
(Rudzinska et al., 2004) where pure sterols are oxidized to 
a greater extent than sterols contained in unsaturated and 
saturated matrices (Lampi et al., 2002; Otaegui-Arrazola 
et al., 2010).
The usual approach to minimizing oxidation is 
by the addition of antioxidants and also through a more 
recently introduced technical procedure to protect sensitive 
oil called microencapsulation (Velasco, Dobarganes, 
Márquez-Ruiz, 2000; Fernandes, Cabral, 2007).
Microencapsulation can be defined as the entrapment 
of a compound or a system inside a dispersed material 
for its immobilization, production, controlled release, 
structuration and functionalization. This process can be 
employed in many industrial and scientific domains, such 
as pharmaceutical, cosmetic and food industries (Poncelet, 
2006).
The products resulting from microencapsulation 
are called microparticles, microspheres or microcapsules, 
differing in morphology and internal structure (Pereira et 
al., 2006; Jyothi et al., 2010).
Drugs are encapsulated for taste and odor masking, 
improvement of gastrointestinal tolerance, controlled 
release after oral administration and oxidative protection 
(Ribeiro et al., 1999; Chan, Lim, Heng, 2000; Tan, Chan, 
Heng, 2009).
The choice of encapsulation material and process 
is governed by three main criteria: the application, 
economics and safety. Biocompatible and biodegradable 
materials are preferable for use in microparticle production 
for medicines, food and pesticides products (Chan, 2011)
Some encapsulation methods involve organic 
solvents or other reagents that are incompatible with 
many biological encapsulants. Solvents are toxic thereby 
limiting widespread applicability, whereas vitamins, 
hormones and unsaturated aliphatic compounds are 
important examples of heat or oxygen labile products 
(Ribeiro et al., 1999; Schoubben et al., 2010).
Ca-alginate beads represent one of the most widely 
used carriers and the success of this simple encapsulation 
method is largely due to the mild conditions needed and the 
low cost of the process (Fundueanu et al., 1999; Florczyk 
et al., 2011).
Alginate, a polymer which occurs naturally in brown 
algae, is a linear 1,4 linked copolymer of β-D-mannuronic 
acid (M) and α-L-guluronic acid (G) residues in varying 
proportions, order and molecular weights (Thu et al., 
1996; Segato, 2007). It exhibits mucoadhesion (Tu et al., 
2005; Wittaya-areeku, Kruenate, Prahsarn, 2006; Rowe, 
Sheskey, Quinn, 2009), biocompatibility, biodegradability 
(Lee et al., 2006; Florczyk et al., 2011), immunogenicity, 
thickening properties and the ability to form gels in the 
presence of multivalent ions (Florczyk et al., 2011).
Thus, an alginate solution is transformed into a 
hydrogel in the presence of divalent cations such as Ca+2 
and Ba+2 (Simpson et al., 2004). The hydrogel is formed 
due to the interaction between guluronic residues and 
divalent cations, yielding a three-dimensional network of 
alginate filaments which are held together mainly by ionic 
interactions (Lee et al., 2006; Reis et al., 2006).
The resultant network depends on the frequency and 
length of guluronic acid residue sequence as well as the 
concentration and type of cation. Alginates having a high 
guluronic acid content develop stiffer, more porous gels, 
which maintain their integrity for longer periods of time. 
Conversely, alginates rich in mannuronic acid residues 
develop softer, less porous gels that tend to disintegrate 
with time (Simpson et al., 2004; Reis et al., 2006).
Since Ca-alginate gel has a macroporous structure 
sensitive to the presence of non-gelling ions, such as 
sodium and magnesium, a membrane coat and/or a filling 
material can be applied to improve stability and decrease 
bead permeability (Ribeiro et al., 1999; Calija et al., 2011).
Alginate microparticles can be treated with a 
polycationic polymer, because electrostatic interaction of 
the alginate carboxyl groups with the polycationic polymer 
encloses the encapsulant, improving drug retention or 
release potential (Ribeiro et al., 1999; Calija et al., 2011). 
Polylysine and chitosan are the most commonly used 
polycation for capsule production, but DEAE – dextran 
has also been applied (Gaserod, Smidsrod, Skjak-Braek, 
1998).
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Chitosan is a natural polymer produced mainly 
from the partial deacetylation of chitin, which occurs 
in the exoskeleton of crustaceans (Rowe, Sheskey, 
Quinn, 2009; Florczyk et al., 2011). It is composed of 
units of β (1-4)-D-glucosamine and β (1-4) N-acetyl-
D-glucosamine in variable proportions. Its functional 
properties depend on average molecular weight, degree of 
acetylation, load distribution and density, viscosity and pH 
of use (Canella, Garcia, 2001; Aranaz et al., 2009; Rowe, 
Sheskey, Quinn, 2009). Chitosan presents mucoadhesion, 
biocompatibility and biodegradability (Ribeiro et al., 
1999; Wittaya-areeku, Kruenate, Prahsarn, 2006), having 
a hydrophilic nature and antibacterial activity (Florczyc 
et al., 2011).
Alginate-chitosan microparticles can be produced 
by a one-stage process, in which a complex coacervate 
membrane is formed when the alginate solution is dripped 
directly into a calcium chloride solution containing 
chitosan (Gaserod, Sannes, Skjak-Braek, 1999; Wittaya-
areeku, Kruenate, Prahsarn, 2006). The other method is 
the two-stage process comprising the primary production 
of Ca-alginate microparticles followed by a membrane 
forming step where the beads produced are suspended in 
a chitosan solution (Gaserod, Sannes, Skjak-Braek, 1999; 
Wittaya-areeku, Kruenate, Prahsarn, 2006).
The aim of this work was to improve the one-stage 
external ionic gelation technique to obtain microparticles 
of alginate-starch-chitosan containing stigmasterol 
dissolved in canola oil using natural biopolymers.
MATERIAL AND METHODS
Material
Sodium alginate (Protanal LF 20/40, FMC 
BioPolymer, U.S.A., with a viscosity of between 100 and 
200mPas and G residue content between 65 and 75%), corn 
starch (DEG, Brazil), Stigmasterol (Fluka, U.S.A., purity 
degree ≥ 90%), Canola oil (Cargill, Brazil), Poloxamer 407 
(Embrafarma, Brazil) and Chitosan (Galena, Brazil) were 
employed. All other chemicals and reagents used were of 
analytical grade.
Purification of Chitosan
Purification of chitosan was performed as described 
by Signini and Campana-Filho (1998). The polymer was 
suspended in acetic acid 0.5 M solution and magnetically 
stirred for approximately 24 hours. The viscous solution 
was filtered through a 5. 10-3 mm glass fibre micro filter 
and a 0.22.10-3 mm cellulose membrane (Millipore). 
Concentrated NH4OH was added drop-wised to the 
filtrate for precipitation of chitosan. The polymer was 
filtered and rinsed with distilled water to pH 7.0 followed 
by methanol. Chitosan was dried at 60 ºC for 24 hours 
and kept in a desiccator over silica gel under vacuum 
for 2 hours. Chitosan was crushed and sieved to afford a 
16-mesh powder.
Characterization of chitosan
Average degree of deacetylation
The average degree of deacetylation was determined 
by conductometric titration as described by Santos et 
al. (2003). Chitosan was solubilized in HCl 0.05 M 
solution for 18 hours with constant stirring at room 
temperature. The chitosan solution was titrated with 
NaOH 0.17 M solution and the conductance measurements 
(μS.cm-1) were performed using a PHTek CD 203 portable 
conductivity meter, under controlled temperature.
Intrinsic viscosity
The intrinsic viscosity was determined according to 
Signini and Campana-Filho (1998), by relating reduced 
viscosity versus chitosan at finite concentration, and 
extrapolating to infinite dilution. Chitosan was dissolved 
in a buffer solution pH 4.5 of acetic acid 0.3 M and sodium 
acetate 0.2 M, under constant agitation for 15 hours. The 
solution was heated in a water bath at 80 °C for 2 minutes, 
cooled at room temperature and after adding a further 
25 mL of buffer solution, was heated again to 80 °C for 
2 minutes. After cooling, the solution was filtered through a 
0.22.10-3 mm cellulose membrane. A solution with relative 
viscosity (t/t0) less than 1.8 was sequentially diluted by 
addition of the acetic acid-sodium acetate buffer solution 
until attaining a relative viscosity of around 1.2. The flow 
times were determined with a Cannon-Fenske capillary 
viscometer (ø = 0.54 mm), thermostated at 25 ºC ± 0.1 ºC 
on an AVS 350 system (Schott-Geräte). The values of the 
flow times represent the average of three independent 
determinations for each dilution.
Preparation of microparticles
Alginate-starch-chitosan microparticles were 
obtained through a one-stage process. A system was 
prepared by dispersing 20 g of canola oil containing 0.2 
g of stigmasterol in 80 g of a sodium alginate aqueous 
solution 1.0% (w / w) containing corn starch 0.3% 
(w/w) and poloxamer 407 0.3% (w/w). The raw material 
percentages refer to the final dispersion. Both phases were 
kept at 60 °C during the dispersion and were spontaneously 
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cooled while stirring at 800 rpm for 15 minutes in a 
mechanical stirrer. The mixture was poured with a syringe 
into a 100mL gelling bath, which contained CaCl2 2.0% 
(w/v) and chitosan 0.5% (w/v) previously dissolved in 
acetic acid 1.0% (v/v).
 The gelling bath (CaCl2/chitosan) was maintained at 
250 rpm rotation in a magnetic stirrer at room temperature. 
The cross-linking time was 60 minutes. After this period, 
microparticles were washed twice with 200 ml of CaCl2 
0.05 M solution containing Tween® 80 1.0% (w/v) and 
then vacuum filtered.
After removal of the excess water, the wet 
microparticles were weighed for later determination of 
residual moisture and particle size. Subsequently, some 
microparticles were dried in an air column until constant 
weight at 50 °C while others were lyophilized. The 
microparticles dried in the air column were weighed and 
prepared for the process of particle size measurement and 
determination of encapsulation efficiency.
Characterization of microparticles 
Morphology
The morphology of the microparticles was observed 
under an optical microscope (Studarlab), and images were 
captured with an Olympus Stylus Tough 8000 digital 
camera and scanning electron microscopy (SEM) (10,001 
Tabletop Phenom).
Microencapsulation yield
The microencapsulation yield was determined by 
the ratio of the total amount of raw material used in the 
process to the dry weight of the microparticles obtained.
Determination of residual moisture
The residual moisture was gravimetrically 
determined by loss on drying. The wet microparticles 
were weighed and dried in an air column at 50 °C for 30 
minutes. The process was repeated until constant weight 
of the sample was reached. The residual moisture was 
expressed in percent according to the equation:
Particle size analysis
The determination of particle size distribution of wet 
and dried microparticles was performed in triplicate, based 
on the method described in the Farmacopeia Brasileira V 
(2010).
For the analysis, sieves of 1.70 mm/10 mesh, 
1.40 mm/12 mesh, 1.00 mm/16 mesh, 710 μm/24 mesh 
were sequentially arranged. The wet microparticles were 
weighed and sieved with vertical and horizontal vibrating 
motions for 10 minutes. The microparticles retained by 
each sieve were weighed.
Encapsulation efficiency
Encapsulation efficiency was determined by 
extracting the encapsulated oil using the modified Bligh 
and Dyer method (Brum, Arruda, Reginato-d’Arce, 
2009). Dried microparticles were placed in 80 mL sodium 
phosphate buffer solution pH 7.4 for 12 hours. After this 
period, chloroform 100 mL and methanol 200 mL were 
added to phosphate buffer solution, forming a solvent 
system in the proportion 0.8:1:2 (v/v). The mixture was 
vigorously stirred and allowed to stand for 12 hours. A 
60-mesh sieve was used to retain waste microparticles 
and the filtrate was transferred to a separatory funnel. 
Chloroform 100 mL and water 100 mL were added to 
the filtrate, so that the final solvent system reached the 
proportion of 1.8:2:2 (v/v). The system was stirred and 
allowed to stand until complete phase separation. The 
chloroform/oil phase was separated and filtered through 
a funnel containing Na2SO4. The filtrate was kept at 
room temperature for solvent evaporation until constant 
oil weight. The ratio of the amount of encapsulated oil 
to the initial oil amount defines encapsulation efficiency 
(EE) and is expressed as a percentage (%) according to 
the equation:
Quantification of encapsulated stigmasterol
Analytical curve
Stigmasterol standard solution 0.5 mg/mL was 
pipetted out into 5 test tubes containing 2 mL of canola 
oil diluted in chloroform 1:50 (w/v), labeled P1, P2, P3, 
P4 and P5 in order to obtain concentrations of 7.5, 8, 75, 
10, 11.25 and 12.5 mg/g. There were also two separate 
test tubes containing only 2 ml of canola oil diluted in 
chloroform 1:50 (w/v) serving as blank and negative 
samples. Thus, 2 mL of the Liebermann-Burchard reagent, 
composed of 60 mL of acetic anhydride and 3 mL of 
sulfuric acid, were added to all samples, except the blank 
tubes, and the volume completed to 9 mL with chloroform. 
The samples remained at room temperature, protected 
from light for 15 minutes. After this period, concentrations 
were measured in a spectrophotometer at 640 nm. The 
procedure was performed in triplicate.
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Quantification of stigmasterol by UV-VIS 
spectrophotometry
For the determination of encapsulated stigmasterol, 
2 mL of Liebermann-Burchard reagent was added to 2 mL 
of oil extracted from the microparticles and diluted to 
1:50 (w/v). The final volume was completed to 9 mL with 
chloroform and the samples stored protected from light at 
room temperature for 15 minutes. The presence of sterols 
produces a characteristic green color whose absorbance 
was measured in a spectrophotometer at 640 nm (Sabir et 
al., 2005; Jain, Bari, Surana, 2009; Daksha et al., 2010).
RESULTS AND DISCUSSION
Purification of Chitosan
Purification is an important process for obtaining 
uniform samples, free of insoluble contaminants and 
completely soluble, resulting in a polymer with suitable 
characteristics for the intended objectives (Signini, 
Campana-Filho, 1998).
Purified polymer minimally interferes in the 
biological systems and is suitable for use as a biomaterial 
(Abbas, 2010).
Purification methods may be performed using either 
hydrochloride or neutralized chitosan. In its neutralized 
form, purification is a process that requires less time, 
material and equipment and increases yield (Signini, 
Campana-Filho, 1998).
The procedure resulted in 78% yield of recovered 
material, in the form of fine pale brown crystalline flakes, 
totally soluble in acidic solutions such as acetic acid and 
hydrochloric acid.
Characterization of chitosan 
Average degree of deacetylation
Average degree of deacetylation of Chitosan is 
defined as the number of amine groups related to the amide 
groups of the polymer chain (Santos et al., 2003). A high 
degree of deacetylation is preferable for interaction with 
alginate guluronic acid residues (Rowe, Sheskey, Quinn, 
2009).
The values of conductance with the corresponding 
titrant volumes were plotted on a graph to find the linear 
variation before and after the equivalence point. Three 
line segments were observed. The first rapid descending 
branch corresponds to neutralization of HCl in excess, 
the second segment depicts neutralization of the amine 
group and the third indicates the excess of base. The two 
stoichiometry points are found by taking the intersection 
of the three lines, where the difference between the two 
points corresponds to the volume of the base required to 
neutralize the amine groups (Santos et al., 2003; Rinaudo, 
2006).
The average degree of deacetylation (DD) is 
calculated using the equation:
where DD is the average degree of deacetylation, V1 and 
V2 are the volume of NaOH (in mL) used in the titration, 
[base] is the concentration of NaOH, M is the mass of 
chitosan (in mg) and 161 is the molar mass of the monomer 
(Santos, Cirilo, Nunes, 2011).
Under the conditions set, the average degree of 
deacetylation of the sample was 84.54%.
Intrinsic viscosity
The solubilization of a polymer in a solvent is a 
very important feature in the viscosimetry process. This 
depends on the concentration, molecular weight and chain 
conformation, and the most suitable conditions for polymer 
solubilization. To avoid poor solubilization of the samples 
or formation of clusters, the method was performed with a 
solvent system of acetic acid 0.3 M/sodium acetate 0.2 M, 
pH 4.5, proposed by Rinaudo (2006).
The intrinsic viscosity [η] was calculated graphically 
by extrapolating the curve of reduced viscosity versus 
concentration to zero concentration. The correlation 
coefficient R2 between the experimental points was 0.9951 
and the straight-line equation expressed by y = 31.606 x 
+ 274.51. Chitosan intrinsic viscosity [η] when (C → 0) 
is 274.51 mL/g.
The chitosan molecular weight was then calculated 
by the Mark-Houwink equation:
where KH is the Huggins constant, a characteristic of the 
polymer, which depends on temperature, solvent system 
used and degree of acetylation, α is the characteristic 
constant of the geometry of the polymer molecule and Mw 
(g.mol-1) is the viscosimetric molar weight. The values of 
the viscosimetric constants were drawn from the literature 
(Battisti, Campana-Filho, 2008).
Based on the values of the constants KH (0.075), 
α (0.76) and intrinsic viscosity (274.51), the chitosan 
viscosimetric molecular weight (Mv) was 48,829 Da.
Chitosan molecular weight affects both the index 
and extent of linkage in the alginate microparticles. 
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The lower molecular weight chitosans (20,000 Da) are 
uniformly distributed over the whole particle, causing a 
significant decrease in interaction between the polymers 
with the increase in acetyl groups. High molecular 
weight chitosans are mainly accumulated on the surface 
because they are too large to enter into the pores (Gaserod, 
Smidsrod, Skjak-Braek, 1998).
Production and characterization of alginate-
starch-chitosan microparticles 
Microparticle production
During sample preparation, special care was taken to 
minimize artefact formation and further reactions of sterol 
oxides, because sterol oxides are less stable than sterols. 
Thus, high temperatures, light and oxygen were avoided 
(Piironen et al., 2000).
Among the common vegetable oils, rapeseed 
and canola oils are considered a good convenient 
source of phytosterols. Brassicasterol, β-sitosterol 
and campesterol together account for 80-88% of total 
sterols. Cholesterol, campesterol, Δ5-avenasterol, Δ7-
sigmastenol, 24-methylene cholesterol, campestanol, 
Δ5,23-stigmastadiene, sitostanol, Δ5,24-stigmastenol and 
Δ7-avenasterol are also present in rapeseed and canola oil 
but at lower levels. Stigmasterol is a major sterol in most 
common vegetable oil. However, it is a minor component 
in rapeseed and canola oil. Typically it does not exceed 
1% of total sterols (Gunstone, 2004).
Canola oil was used in this work because of its low 
stigmasterol content and high level of sterols. In addition, 
some studies have demonstrated the influence of lipid 
matrices, including canola oil, for decreasing the oxidation 
process (Lampi et al., 2002).
Researchers have found a correlation between 
degree of saturation of the lipid matrix and sterol oxidation 
rate (Otaegui-Arrazola et al., 2010). However, studies on 
the effects of co-oxidizing matrix lipids are controversial 
because some indicate that sterol oxidation is enhanced by 
unsaturated lipids, while others have shown that oxidation 
is more marked in saturated than in unsaturated lipid 
matrices (Lampi et al., 2002).
A study of thermo-oxidation of sterols was carried 
out in stigmasterol and rapeseed oil. Both substances were 
heated at 180+5 ºC for up to 6 and 24 hours, respectively. 
Thermo-oxidation of sterols was slower in rapeseed 
oil than bulk stigmasterol. The result indicates that this 
oxidation, akin to autoxidation, is significantly dependent 
on the sample area subjected to air and the area to volume 
ratio, which were much larger in the bulk stigmasterol 
than in the rapeseed oil samples. Moreover, the profile 
of products was more stable in rapeseed oil than in 
stigmasterol where further reactions of oxidation products 
occurred (Lampi et al., 2002).
The microencapsulation technique can be used to 
minimize the oxidation process. Accelerated stability 
testing was performed by Oliveira (2007) using 
microencapsulated stigmasterol and a stigmasterol 
standard solution. The presence of oxidation products after 
60 days was confirmed in both the stigmasterol standard 
solution and the stigmasterol encapsulated with stearic 
acid. The latter showed a lower amount of oxidation 
products. Stigmasterol encapsulated with gelatin showed 
no formation of oxidation products.
Some encapsulation methods involve the use of 
organic solvents or other reagents and high temperatures 
to achieve the same goal, however, these conditions can 
be incompatible with many biological encapsulants, such 
as plant cells, mammalian cells, yeasts, bacteria, insulin, 
magnetite or food products such as edible oils (Poncelet 
et al., 1992; Fundueanu et al., 1999).
The use of various gel-forming proteins (collagen 
and gelatin) and polysaccharides (agar, calcium alginate 
and carrageenan) has resulted in milder, biocompatible 
immobilization techniques (Poncelet et al., 1992).
In this context, the external ionic gelation technique 
for microencapsulation of stigmasterol was chosen due to 
the milder process, without the use of organic solvents and 
high temperatures.
Between the two most common methods of external 
ionic gelification to obtain alginate-starch-chitosan 
microparticles, the one-stage process was chosen because 
it allows the formation of less permeable microparticles, 
due to the different ways of forming the alginate-chitosan 
complex. While the alginate is in gel form in the two-
stage process, the membrane in the one-stage process 
is formed when both polymers are in solution, leading 
to the formation of particles with small pores. These 
resulting small pores are probably the reason why these 
capsules bind small amounts of chitosan as they restrict 
their diffusion into the matrix (Gaserod, Smidsrod, Skjak-
Braek, 1998; Gaserod, Sannes, Skjak-Braek, 1999).
The presence of starch in the formulation provided 
the microparticles with greater stability during the drying 
process, since the suitable mixtures of polymers consist 
of convenient and effective methods of improving the 
performance of polymeric materials. Previous studies 
have demonstrated that intermolecular interactions and 
good molecular compatibility occur between starch and 
alginate (Wang et al., 2010). The ratio of alginate:starch 
was 1:0.3 (w/w), because larger proportions can damage 
the alginate-chitosan cross-linking by competing in the 
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interpolymer interactions, leading to a failed or incomplete 
alginate-chitosan complex.
The use of poloxamer 407, a nonionic dispersing 
agent with a hydrophile-lipophile balance (HLB) of 
between 18 and 23, allows for the proper dispersion of the 
oil phase over the aqueous phase of the system, avoiding 
nucleation and poor distribution of oil, thus contributing 
to the encapsulation efficiency of the drug (Zanin et al., 
2002; Culpi et al., 2010).
Drying process
Two drying processes have been tested, lyophilization 
and the air column. In the first case microparticles showed 
morphological changes (Figure 1a and 1b) even in the 
presence of starch as the filling material, while the second 
process maintained their spherical shape (Figure 1c and 1d). 
Chan et al. (2011) argued that when microparticles are 
lyophilized, they tend to exhibit different sizes, fragility 
in their mechanical structure and high porosity, factors 
that influence the stability of the encapsulated substance. 
The use of starch as a filling material can improve these 
characteristics, maintaining the spherical shape and 
decreasing the shrinkage of the microparticles.
Product yield
The average yield of microparticles was 94.87% in 
relation to the raw material used.
Morphology, residual moisture and particle size
The microparticles were spherical, slightly oval, 
with average residual moisture of 60.59%. In the wet 
microparticle size analysis, 98.40% were retained by 
a 10-mesh sieve, and after drying process, 71% were 
retained by a 12-mesh sieve.
Encapsulation efficiency
For oil content determination in the microparticles, 
some studies report the use of organic solvents such 
as hexane, chloroform and carbon tetrachloride for oil 
extraction (Peniche et al., 2004, Tan, Chan, Heng, 2009). 
Another method employed consists of the disruption of the 
microparticles by the use of a pH 7.4 sodium phosphate 
buffer solution or sodium citrate buffer solution 0.055 M to 
remove the Ca +2 ions from the microparticles. This process 
causes destabilization of the three-dimensional network 
and releases the oil to the medium making it available for 
dissolution in an organic solvent and for quantification 
after solvent evaporation (Ribeiro et al., 1999).
In previous studies, our group has tested oil 
extraction by using organic solvents including chloroform 
and hexane, the phosphate buffer solution procedure 
and the Bligh and Dyer method, with a solvent system 
of chloroform: methanol: water ratio of 1:2:0.8 (v/v). 
In the first case, the absence of oil droplets within the 
microparticles under an optical microscope was observed. 
FIGURE 1 - (a) Lyophilized microparticles without starch; (b) Lyophilized microparticles with starch; (c) Microparticles without 
starch dried in air column (d) Microparticles with starch dried in air column at mo (40x). SOURCE: The author (2011).
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Nevertheless, at the end of the process, the residues from 
the microparticles were found to be oily, suggesting 
the presence of oil in the residues. The same result was 
obtained using the microparticle disruption method 
in phosphate buffer solution pH 7.4. Therefore, it was 
decided to work with the Bligh and Dyer method. The 
microparticles were left in contact with the solvent mixture 
for 12 hours, with periodic agitation. After this period, it 
was verified that the standard method was unable to extract 
all the oil from the microparticles, and thus required some 
adaptation.
A modified Bligh and Dyer method was then 
performed. Initially, a phosphate buffer solution pH 7.4 
was used instead of water for membrane destabilization. 
After this first stage, chloroform and methanol were added 
to the mixture, maintaining the proportion suggested by 
Bligh and Dyer (1:2:0.8). At the end of the extraction 
process, no oil was present in the waste of microparticles.
This technique presented an average encapsulation 
efficiency (EE) of 90.42%.
Quantification of stigmasterol by UV-VIS 
spectrophotometry
The main advantages of UV-VIS spectrophotometry 
include ease of operation, good sensitivity and accuracy, 
moderate selectivity and wide applicability (Gil, 2007).
The Liebermann-Burchard reaction used for 
determination of steroids or other sterols (natural 
sterols are crystalline 3-hydroxy-steroids containing an 
aliphatic side chain) comprises a reaction in a mixture of 
acetanhydride and a relatively small amount of sulfuric 
acid (Burke et al., 1974; Xiong, Wilson, Pang, 2007).
Sterols react with various strong acids to give 
colored products, and although these reactions have been 
used empirically for many years for the qualitative and 
quantitative determination of sterols, their underlying 
mechanisms are not yet clearly understood (Burke et al., 
1974).
The linearity of the method was established using 
stigmasterol standard solution. The analytical curve 
showed a Pearson regression coefficient (R2) of 0.9989 
and standard deviation of less than 5.0%. The analysis of 
variance for each standard concentration was performed by 
the SISVAR program (Ferreira, 2000) and no statistically 
significant difference was found on Tukey’s test (p<0.05).
Three batches of microparticles were analyzed in 
triplicate for quantification of stigmasterol--showing a 
standard deviation of less than 5.0%--whose final average 
stigmasterol concentration was 9.97 mg/g compared to 
the initial concentration of 10.00 mg/g (per gram of oil).
CONCLUSION
Alginate-starch-chitosan microparticles containing 
stigmasterol solubilized in canola oil were successfully 
produced by the one-stage external ionic gelation 
method. Canola oil, in which stigmasterol is dissolved, 
has an important role in decreasing oxidation product 
formation. Alginate is well suited to form the matrix 
for the microencapsulation of various substances such 
as sterols and edible oils. Since alginate gels have a 
porous structure, a filling material such as starch and a 
chitosan membrane coat was applied to provide stability 
and reduce bead permeability. External ionic gelation 
using an alginate-starch-chitosan blend as a wall material 
potentially has widespread applications due to its easy and 
mild production, relatively high encapsulation efficiency 
and oxidative protection. The resultant microparticles are 
spherical, uniform, and slightly rough on the surface, with 
an average size of 1.4 mm. A production yield of 94.87% 
and encapsulation efficiency of 90.42% was obtained by 
this easy-to-perform method.
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